EyePoint
(NASDAQ) EYPT
EyePoint Financials at a Glance
Market Cap
$1.04B
Revenue (TTM)
$31.37M
Net Income (TTM)
$231.96M
EPS (TTM)
$-3.16
P/E Ratio
-3.95
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$12.45
Volume
35,541
Open
$12.93
Price
$12.45
Volume
35,541
Open
$12.93
Previous Close
$12.45
Daily Range
$12.45 - $13.07
52-Week Range
$3.91 - $19.11
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$12.45
Volume
35,541
Open
$12.93
Previous Close
$12.45
Daily Range
$12.45 - $13.07
52-Week Range
$3.91 - $19.11
EYPT News
EYPT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout EyePoint
Industry
Pharmaceuticals
Sector
Health CareEmployees
214
CEO
Jay S. Duker, MD
Website
www.eyepointpharma.comHeadquarters
Watertown, MA 02472, US
EYPT Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-8%
Net Income Margin
-7%
Return on Equity
-72%
Return on Capital
-74%
Return on Assets
-64%
Earnings Yield
-25.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.04B
Shares Outstanding
83.43M
Volume
35.54K
Short Interest
0.00%
Avg. Volume
1.32M
Financials (TTM)
Gross Profit
$29.30M
Operating Income
$243.43M
EBITDA
$243.43M
Operating Cash Flow
$240.11M
Capital Expenditure
$3.28M
Free Cash Flow
$243.39M
Cash & ST Invst.
$306.09M
Total Debt
$20.77M
EyePoint Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$620.00K
-94.6%
Gross Profit
$245.00K
-97.7%
Gross Margin
39.52%
N/A
Market Cap
$1.04B
N/A
Market Cap/Employee
$6.32M
N/A
Employees
165
N/A
Net Income
$67.61M
-63.3%
EBITDA
$70.34M
-72.3%
Quarterly Fundamentals
Net Cash
$285.31M
-18.3%
Accounts Receivable
$651.00K
+7.2%
Inventory
$1.81M
-21.3%
Long Term Debt
$20.77M
-5.0%
Short Term Debt
$0.00
N/A
Return on Assets
-63.73%
N/A
Return on Invested Capital
-74.45%
N/A
Free Cash Flow
$66.03M
-82.2%
Operating Cash Flow
$65.05M
-81.4%